Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists
Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
1. A method of treating an inflammatory condition comprising administering a therapeutically effective amount of an isolated antibody or fragment thereof to a patient in need thereof for a time sufficient to treat or prevent the inflammatory condition, wherein the antibody binds toll-like receptor 3 (TLR3) amino acid residues K416, K418, L440, N441, E442, Y465, N466, K467, Y468, R488, R489, A491, K493, N515, N516, N517, H539, N541, S571, L595, and K619 of SEQ ID NO: 2.
2. A method of treating an inflammatory condition comprising administering a therapeutically effective amount of an isolated antibody or fragment thereof to a patient in need thereof for a time sufficient to treat or prevent the inflammatory condition, wherein the isolated antibody comprises a heavy chain variable region and a light chain variable region or fragment thereof and the isolated antibody heavy chain variable region Chothia residues W33, F50, D52, D54, Y56, N58, P61, E95, Y97, Y100, and D100b and the isolated antibody light chain variable region Chothia residues Q27, Y32, N92, T93, L94, and S95 bind toll-like receptor 3 (TLR3) that has the amino acid sequence shown in SEQ ID NO: 2.
3. The method of claim 1 or 2 , wherein the inflammatory condition is an inflammatory pulmonary condition, inflammatory bowel disease, autoimmune disease, systemic inflammatory condition, or rheumatoid arthritis.
4. The method of claim 3 , wherein the inflammatory pulmonary condition is asthma, chronic obstructive pulmonary disease (COPD), airway hyperresponsiveness, or is induced by Nontypeable Haemophilus influenza.
5. The method of claim 3 , wherein the systemic inflammatory condition is cytokine storm or hypercytokinemia, systemic inflammatory response syndrome (SIRS), graft versus host disease (GVHD), acute respiratory distress syndrome (ARDS), severe acute respiratory distress syndrome (SARS), catastrophic anti-phospholipid syndrome, severe viral infections, influenza, pneumonia, shock, or sepsis.
6. The method of claim 5 , wherein the inflammatory condition is associated with gastrointestinal ulceration.
7. The method of claim 6 , wherein the gastrointestinal ulceration is associated with infectious colitis, ischemic colitis, collagenous or lymphocytic colitis or necrotizing enterocolitis.